| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0149-2918(97)80014-8 |
| P698 | PubMed publication ID | 9444449 |
| P2093 | author name string | J H Anderson | |
| L Vignati | |||
| P W Iversen | |||
| P2860 | cites work | Monomeric insulins and their experimental and clinical implications | Q37977223 |
| Receptor-binding region of insulin | Q39975406 | ||
| The relationship between blood glycosylated haemoglobin and home capillary blood glucose levels in diabetics | Q41614067 | ||
| Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. | Q51584722 | ||
| Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. | Q53968000 | ||
| 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over Design | Q69183582 | ||
| Lys(B28), Pro(B29)-human insulin: Effect of injection time on postprandial glycemia | Q71809369 | ||
| Characteristics of glycemic stability | Q72148301 | ||
| Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group | Q73183763 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1408-1421 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Clinical Therapeutics | Q15716601 |
| P1476 | title | Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group | |
| P478 | volume | 19 |
| Q46602351 | A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes |
| Q35585217 | An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK. |
| Q34982117 | Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures |
| Q37111783 | Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus. |
| Q24656013 | Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis |
| Q77733099 | Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group |
| Q33995665 | Insulin analogues and management of diabetes mellitus |
| Q34982099 | Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus |
| Q36750094 | Insulin lispro: a review of its use in the management of diabetes mellitus |
| Q51567062 | Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. |
| Q92232936 | Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes |
| Q43554627 | Role and modalities of insulin treatment in type 2 diabetics |
| Q24246142 | Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus |
| Q24246326 | Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus |
| Q90581308 | Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus |
| Q26471380 | Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus |
Search more.